about
T cell ageing: effects of age on development, survival & functionCharacterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicityICOS is essential for effective T-helper-cell responsesThe B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responsesRole of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection.Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells.Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activityGene therapy: development of immunostimulatory treatments for cancer.PD-1 gene promoter polymorphisms correlate with a poor prognosis in non-small cell lung cancerThe role of heat shock proteins and their receptors in the activation of the immune system.Challenges to achieving clinical transplantation tolerance.CD137-mediated immunotherapy for allergic asthmaActivation and inhibition of lymphocytes by costimulation.CD8+CD28- T cells: certainties and uncertainties of a prevalent human T-cell subset.T lymphocyte activation--an inside overview.Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.Principles of tumor immunosurveillance and implications for immunotherapy.Contrasting alloreactive CD4+ and CD8+ T cells: there's more to it than MHC restriction.Augmented lymphocyte expansion from solid tumors with engineered cells for costimulatory enhancementT-cell costimulatory pathways in allograft rejection and tolerance.Optimal modes and targets of gene therapy in transplantation.Crossing the bridge: large animal models in translational transplantation research.Role of 4-1BB:4-1BB ligand in cancer immunotherapy.T lymphocyte dependence of the antibody response to 'T lymphocyte independent type 2' antigens.Role of T cell co-stimulation in murine models of allergic asthma.Hu.4-1BB-Fc fusion protein inhibits allergic inflammation and airway hyperresponsiveness in a murine model of asthmaRotavirus infection alters peripheral T-cell homeostasis in children with acute diarrhea.Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40.Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses.T cell costimulatory molecules in anti-viral immunity: Potential role in immunotherapeutic vaccines.Dendritic cells in asthma: a function beyond sensitization.CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool.Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40.Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasis.SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccinesRetrogenic ICOS Expression Increases Differentiation of KLRG-1hiCD127loCD8+ T Cells during Listeria Infection and Diminishes Recall Responses.OX40 engagement stabilizes Mxd4 and Mnt protein levels in antigen-stimulated T cells leading to an increase in cell survival.From current immunosuppressive strategies to clinical tolerance of allografts.OX40 ligand expression abrogates the immunosuppressive function of retinal pigment epithelium.
P2860
Q27015121-2AD275B0-B06A-49BA-96F1-27346BDE044DQ28139731-9ECF3B1B-19EE-4D81-8CB5-686EDC0E6954Q28217502-2C07960E-99DF-4A8B-8916-42A66BFBE0B8Q28594859-735BBA83-6773-4D77-A825-BC14C1531F6BQ28594992-331BD2D7-F8B9-45B5-B2D8-5320E877F7D2Q33835246-4E629807-C017-4FCA-9153-9E32BB20C9B6Q33896804-FC1AF67D-7BAB-4BCB-9260-53846F79109AQ34106843-12275066-2303-4AF3-96E8-184B90C108B9Q34187915-3353527C-335F-43B5-9573-28FEA536F1E4Q34265875-95B9DDC2-05E7-435A-A5D8-6DE05FA7AF18Q34280951-96B802F6-DAB3-495D-B32A-F1DC4B1E2216Q34387873-25946662-04C6-49DE-BFA2-86795B9D59DCQ34435149-921AACA9-BF3C-4665-AF4C-0B92D4DE87D5Q34517906-0D3AC1EB-EE7D-4F88-9C61-DE287D85DE23Q34546418-F598CA42-60DF-46A8-9B79-AEC03E81559FQ34567937-F33CEC7F-D34F-4ACD-B288-CBCD8096DE62Q34897236-AB8D082E-B816-4B96-9A2A-870FAE315064Q35043113-2508DBA2-DAB4-4A84-97E6-FF56E23EA3CAQ35072094-A5601EE1-9341-4BD6-A795-7FF12F4EBBC7Q35382043-4F469ACC-FC31-43C9-82FC-92D91E2F3677Q35583511-E372F87B-9B34-4FDB-8A31-ED64F39B4F71Q35583526-496BC241-15DA-46FD-A857-F98E11D88C8FQ35583529-20C877FF-D581-4A53-A489-2F7A6E423F82Q35606360-BBAD8528-2371-4987-9660-867E6052D1F3Q35608835-35EBB792-C639-403D-92CC-1D05DBCC62C9Q35628016-88C08803-4EA9-4396-A3A9-BB50E1DAF4BEQ35649268-142BD715-5662-4938-A80C-59731F3FA0C9Q35785249-D2BECE11-F722-4BFF-B06A-88155F78C05DQ35790354-F75272AE-63DE-43D9-8F0C-3832E29F3988Q36017811-9E71156C-48DB-4189-AD0C-8430DA95D094Q36170783-CFFA1E40-93C3-4EFE-BBF4-B448072D6F1AQ36257999-F27942A5-6C81-46F4-8CAF-7E83328CDDF6Q36371828-C45BCD49-73A8-4844-9F93-39F3B9004392Q36376225-DD041C99-5D82-4C46-B78E-D154AF5CF3F7Q36376714-39C3D391-4317-4628-82A9-9E95D60EE826Q36487245-FA174022-5B86-41F6-8E85-B49D0AC52A73Q36592988-13F39871-05ED-46C1-903C-C93C7543E8C5Q36618831-AB986B41-8F60-4ADB-B418-0E0FE4734782Q36689232-CD3C58F0-93FA-4576-8F28-7A562B9C1C2CQ36707135-B9F6B71C-46CE-4D33-8C68-2B9982BE6464
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
T cell co-stimulatory molecules other than CD28.
@ast
T cell co-stimulatory molecules other than CD28.
@en
type
label
T cell co-stimulatory molecules other than CD28.
@ast
T cell co-stimulatory molecules other than CD28.
@en
prefLabel
T cell co-stimulatory molecules other than CD28.
@ast
T cell co-stimulatory molecules other than CD28.
@en
P1476
T cell co-stimulatory molecules other than CD28.
@en
P2093
DeBenedette MA
P304
P356
10.1016/S0952-7915(99)80046-6
P577
1999-06-01T00:00:00Z